This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1985 Oct;57(222):611-35.

Renal handling of proteins in normal and disease states

B E Sumpio, J P Hayslett

PMID: 4080952

Renal handling of proteins in normal and disease states

B E Sumpio et al. Q J Med. 1985 Oct.

. 1985 Oct;57(222):611-35.

Authors

B E Sumpio, J P Hayslett

PMID: 4080952

No abstract available

PubMed Disclaimer

Similar articles

Proteinuria: a review of glomerular permeability in the normal and in various disease states.
Pollak VE, Pesce AJ. Pollak VE, et al. Perspect Nephrol Hypertens. 1977;6:155-74. Perspect Nephrol Hypertens. 1977. PMID: 320550 Review. No abstract available.
Renal clearance of 15 plasma proteins in renal disease.
Bienenstock J, Poortmans J. Bienenstock J, et al. J Lab Clin Med. 1970 Feb;75(2):297-306. J Lab Clin Med. 1970. PMID: 5461134 No abstract available.
[Changes in glomerular permeability and tubular reabsorption of serum proteins after hemodialysis].
Migone L, Maiorca R, Scarpioni L, Cambi V, Carrara GC, Dall'Aglio P. Migone L, et al. Minerva Nefrol. 1969 Jan-Feb;16(1):15-22. Minerva Nefrol. 1969. PMID: 5768262 Italian. No abstract available.
Biology of proteoglycans in renal diseases.
Kanwar YS. Kanwar YS. Nihon Jinzo Gakkai Shi. 1992 May;34(5):431-3. Nihon Jinzo Gakkai Shi. 1992. PMID: 1469800 Review. No abstract available.
[Proteinuria].
Ado MA, Belikova TN. Ado MA, et al. Klin Med (Mosk). 1974 Apr;52(4):24-7. Klin Med (Mosk). 1974. PMID: 4459563 Russian. No abstract available.

See all similar articles

Cited by

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Casey JL, King DJ, Chaplin LC, Haines AM, Pedley RB, Mountain A, Yarranton GT, Begent RH. Casey JL, et al. Br J Cancer. 1996 Nov;74(9):1397-405. doi: 10.1038/bjc.1996.555. Br J Cancer. 1996. PMID: 8912535 Free PMC article.
Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.
Casey JL, Napier MP, King DJ, Pedley RB, Chaplin LC, Weir N, Skelton L, Green AJ, Hope-Stone LD, Yarranton GT, Begent RH. Casey JL, et al. Br J Cancer. 2002 May 6;86(9):1401-10. doi: 10.1038/sj.bjc.6600198. Br J Cancer. 2002. PMID: 11986771 Free PMC article. Clinical Trial.
Urinary phospholipase A2 excretion in chronic pancreatic diseases.
Fabris C, Basso D, Panozzo MP, Del Favero G, Meggiato T, Plebani M, Ferrara C, Fogar P, Zaninotto M, Naccarato R. Fabris C, et al. Int J Pancreatol. 1992 Jun;11(3):179-84. doi: 10.1007/BF02924183. Int J Pancreatol. 1992. PMID: 1517657
Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
Casey JL, Pedley RB, King DJ, Green AJ, Yarranton GT, Begent RH. Casey JL, et al. Br J Cancer. 1999 Nov;81(6):972-80. doi: 10.1038/sj.bjc.6690795. Br J Cancer. 1999. PMID: 10576653 Free PMC article.
Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.
Ilarde A, Tuck M. Ilarde A, et al. Drugs Aging. 1994 Jun;4(6):470-91. doi: 10.2165/00002512-199404060-00004. Drugs Aging. 1994. PMID: 8075474 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

AM 18061/AM/NIADDK NIH HHS/United States

LinkOut - more resources

Medical
- MedlinePlus Health Information